Oxford-AstraZeneca COVID-19 vaccine-induced acute localized exanthematous pustulosis.

J Dermatol

Department of Dermatology, Skin Institute, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.

Published: November 2021

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652451PMC
http://dx.doi.org/10.1111/1346-8138.16138DOI Listing

Publication Analysis

Top Keywords

oxford-astrazeneca covid-19
4
covid-19 vaccine-induced
4
vaccine-induced acute
4
acute localized
4
localized exanthematous
4
exanthematous pustulosis
4
oxford-astrazeneca
1
vaccine-induced
1
acute
1
localized
1

Similar Publications

Key functions of antibodies, such as viral neutralisation, depend on high-affinity binding. However, viral neutralisation poorly correlates with antigen affinity for reasons that have been unclear. Here, we use a new mechanistic model of bivalent binding to study  >45 patient-isolated IgG1 antibodies interacting with SARS-CoV-2 RBD surfaces.

View Article and Find Full Text PDF

New-onset cutaneous lichen planus following Vaxzevria (Oxford-AstraZeneca) COVID-19 vaccination.

SAGE Open Med Case Rep

December 2024

Department of Dermatology, College of Medicine, University of Saskatchewan, Regina, SK, Canada.

We report a 56-year-old male who developed cutaneous lichen planus (LP) following Vaxzevria (Oxford-AstraZeneca) COVID-19 vaccination. Multiple topical and systemic therapies were tried with limited success; however, partial improvement was observed with narrow-band UVB (NB-UVB) phototherapy. This report adds to the growing evidence of new-onset LP following COVID-19 vaccination and underscores the need for careful reporting, monitoring, and management of vaccine-related adverse effects.

View Article and Find Full Text PDF

[Events attributable to Vaxzevria vaccine in pregnant women from a first-level hospital in Puebla].

Rev Med Inst Mex Seguro Soc

September 2024

Instituto Mexicano del Seguro Social, Unidad de Medicina Familiar No. 55, Servicio de Medicina Familiar. Puebla, Puebla, México.

Background: COVID-19 is a severe acute respiratory syndrome caused by SARS-CoV-2. This disease had a high mortality rate and turned into a pandemic, which is why it was considered a severe public health problem. In this context, pregnant patients were a vulnerable group and, consequently, an effective vaccine was necessary.

View Article and Find Full Text PDF

Background And Aim: The COVID-19 pandemic has profoundly impacted global health, necessitating the rapid development of vaccines to reduce its effects. However, concerns among healthcare workers regarding vaccine safety and side effects have led to increased hesitancy towards COVID-19 vaccination. Therefore, this study aims to assess the severity of adverse effects and associated factors of three COVID-19 vaccines among healthcare workers in Iraqi Kurdistan.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!